DAL vs LAB
Delta Air Lines Inc (DAL) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. LAB currently screens at market cap $317.1M.
Not investment advice. Open the DAL and LAB stock pages for the full models.
Not investment advice.